DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...

Dyadic International, Inc. (NASDAQ:DYAI – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday .The stock has a fifty day moving average of $1.40 ...

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a ...

Dyadic International, Inc., a biotechnology firm specializing in large-scale protein production for vaccines and therapeutics, provided an update on its business development efforts, particularly ...

Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building ...

Interested parties can request meetings by contacting [email protected]. About Dyadic International, Inc. Dyadic International, Inc. is a global biotechnology company focused on building ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investing.com - Dyadic reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Dyadic announced earnings per share ...